Review
Copyright ©The Author(s) 2016.
World J Exp Med. Feb 20, 2016; 6(1): 21-36
Published online Feb 20, 2016. doi: 10.5493/wjem.v6.i1.21
Table 3 Patients where surveillance program is suggested by International Societies for the Study of the Liver (AASLD, EASL-EORTC, JSH, APASL)
SocietyTarget populationTarget population
APASL, 2010Chronic hepatitisCirrhosis
No recommendationHBV and HCV cirrhosis
AASLD, 2011HBV-positive patientsHBV and/or HCV cirrhotics
Male Asian HBV+ > 40 yrFourth stage PBC
African > 20 yr; Familial predisposition + for HCCa1-antitrypsin deficit
Autoimmune hepatitis
NASH
JSH, 2011HBV and HCV chronic hepatitisNon viral cirrhosis
HBV and HCV cirrhosis
EASL, 2012HBV + active hepatitisChild A and B cirrhosis
HCV + hepatitis with advanced fibrosis F3 (Metavir)Child C cirrhosis with indication to liver transplantation